« Back
Potent transcriptional activation with CRISPRa using synthetic crRNA
Poster Title: Potent transcriptional activation with CRISPRa using synthetic crRNA
Submitted on 22 Jun 2018
Author(s): Žaklina Strezoska, Elena Maksimova, Eldon T. Chou, Maren Mayer Gross, Shawn McClelland, Melissa L. Kelley, and Anja van Brabant Smith
Affiliations: Dharmacon, part of Horizon Discovery Group
This poster was presented at Keystone Symposia, Precision Genome Editing with Programmable Nucleases
Poster Views: 702
View poster »

Poster Information
Abstract: These data show that using a dual synthetic gRNA approach provides benefits that are applicable from simply upregulating a gene to systematic functional gene analysis in an arrayed screening format.

The CRISPR-Cas system derived from Streptococcus pyogenes has been adapted to upregulate any gene in its endogenous context, enabling overexpression experiments without a need for exogenous overexpression plasmids. For CRISPR activation (CRISPRa), the guide RNA forms a complex with a nuclease-deactivated Cas9 (dCas9, D10A and H840A) which is in turn fused to transcriptional activators. The machinery then acts upstream of the transcription start sites to upregulate expression of a target gene. The ease of programming the CRISPRa system with small RNA guides is transformative for performing gain-of function studies as an alternative method for identification of gene functions that might be undiscovered with loss-of function methods alone.

Here we demonstrate a strategy to conduct CRISPRa experiments using synthetic crRNA reagents. We examine the functionality and advantages of using the synthetic guide RNA approach for CRISPRa in multiple cell lines including pooling of crRNAs to enhance target gene activation, as well as activating multiple genes simultaneously. Additionally, we demonstrate transcriptional activation leading to a significant increase in the target’s protein level, which in turn causes phenotypic effects by inhibiting or activating downstream genes. This demonstrates that CRISPRa using synthetic crRNAs could be used for low- or high-throughput studies of downstream signaling and pathway analysis. The methods presented are broadly applicable as a strategy to upregulate any gene including systematic functional gene analysis in an arrayed screening format.
Summary: Here we look at the advantages of a two-part synthetic guide RNA approach for CRISPRa. We tested our methods in multiple cell lines, observed pooling of crRNAs to enhance target activation, and multiplexed gRNAs for simultaneous activation of different targets. We also show CRISPRa leading to an increase in the target’s protein level, which in turn, causes downstream phenotypic effects. References: Report abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters

automated, low-cost, miniaturized RNA-Seqand DNAseqlibrary preps
SrimeenakshiSrinivasan2, PaymanehMalihi3, Peter De Hoff2, Tiffany Herrero2, To Cuong2, Joby Jenkins1, Louise Laurent2, James Hicks3, Peter Kuhn3

miniaturization and automation of CEL-Seq2 and SMART-Seq2 using the mosquito liquid handler
Josip Herman1, Jon Penterman2, Sagar1, Andreas Diefenbach3, Antigoni Triantafyllopoulou4, Anne F. Hammerstein5, Joby Jenkins5, Dominic Grün1, Stuart S. Levine2 and Klaus Hentrich5

ExpiSf™ Expression system: A Chemically Defined Baculovirus-Based System for Enhanced Protein and Virus Production in Sf9 Cells
Kenneth Thompson, Maya Yovcheva, Sara Barnes, Melissa Cross, Katy Irvin, Natasha Lucki, Henry Chiou, and Jonathan Zmuda

Tres métodos moleculares para la genotipificación del virus de la Hepatitis C (VHC): una estrategia en pos de la seguridad del paciente
Andy Caballero, Sonali Marrero y Karla Montero

Comparación de tres pruebas moleculares para el diagnóstico y la evaluación de la resistencia a claritromicina de H. pylori en heces
Andy Caballero, Nelson Piñero